BioTuesdays

Category - Feature

Feature

In conversation with Todd Wyche

By Len Zehr As CEO and a co-founder of Brinson Patrick Securities, Todd Wyche has championed the use and growth of at-the-market offerings (ATMs) for the past 17 years for REITs, energy companies and most recently...

July 2, 2013
Feature

Avivagen shifts to commercial mindset from R&D

By Len Zehr Cameron Groome, who moved into the executive suite at Avivagen (TSX-V:VIV) in March, has transformed the focus of the animal wellness company to a business and product development engine and away from an...

June 18, 2013
Feature

Oramed readies oral insulin study in U.S.

By Len Zehr Oramed Pharmaceuticals (NASDAQ:ORMP) is awaiting a decision from the FDA, possibly later this week, to conduct a sub-study of the safety of its oral insulin candidate, ORMD-0801, before proceeding to a...

May 7, 2013
Feature

Vaxil trial validates vaccine technology

By Len Zehr Results of a recent clinical trial of Vaxil Bio’s (TASE:VAXL) ImMucin cancer vaccine in patients with multiple myeloma has validated the company’s VaxHit technology by demonstrating safety and a strong...

April 23, 2013
Feature

OnPoint’s Big-Data Equals Big Opportunity

By Len Zehr OnPoint Medical Diagnostics (OTCQB:ONMD) is pioneering a “big-data” platform for delivering measurable, objective and automated quality assurance (QA) solutions for magnetic resonance imaging...

April 16, 2013